Sharon Zehe, J.D., an attorney at Mayo Clinic and Vice President of Business Affairs for Mayo Medical Laboratories, recently presented at the HIMSS Precision Medicine Summit in Boston on "Four Issues for Providers of Precision Medicine."
Fergus Couch, Ph.D., Awarded Breast Cancer Research Foundation Grant - Insights
The Breast Cancer Research Foundation has awarded a research grant to Fergus Couch, Ph.D., for his research proposal, “Inherited Genetic Risk Factors for Breast Cancer.” Dr. Couch will receive $250,000 to use toward his research efforts...
Message to Our Health Care Partners During Unsettling Times - Insights
As we enter a second week of protest and unrest throughout the nation sparked by the deaths of George Floyd and Ahmaud Arbery, we want to recognize the heartache and pain felt because of these events. Added to the uncertainty with...
Challenges of Patient Education: Helping Patients Understand Relevant Medical Information - Insights
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Cori Berg, M.S.N., R.N., instructor in nursing for the Center for
Patient Story Features the Importance of Neuroimmunology - Insights
Sean Pittock, M.D., and Andrew McKeon, M.B., B.Ch., M.D., were featured in a Post Bulletin series about autoimmune neurology disorders and the research and services that Mayo Clinic offers patients.
Matthew Binnicker, Ph.D., on Testing for Viral Gastroenteritis - Insights
Matthew Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, recently spoke with Consultant360 regarding testing for viral gastroenteritis.
Mayo Clinic Laboratory and pathology research roundup: October 19 - Insights
This week’s research roundup features: Autopsy validation of progressive supranuclear palsy-predominant speech/language disorder criteria.
Mayo Clinic Laboratory and pathology research roundup: October 12 - Insights
This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.
Mayo Clinic Laboratory and pathology research roundup: June 7 - Insights
Featured abstract: Nuclear GSK-3β and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN.
Although these sites may offer convenience, Dr. Morice cautions that it's important to understand the potential drawbacks.